Healthcare provider profile · identity verified

Frank Michels, MD

Family Practice · BILLINGS, MT · NPI 1215971155

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	358	33
Gabapentin	Gabapentin	325	41
Atorvastatin Calcium	Atorvastatin Calcium	314	40
Sertraline Hcl	Sertraline Hcl	252	31
Eliquis	Apixaban	227	22
Pantoprazole Sodium	Pantoprazole Sodium	221	35
Potassium Chloride	Potassium Chloride	199	36
Furosemide	Furosemide	192	31
Omeprazole	Omeprazole	164	27
Metoprolol Tartrate	Metoprolol Tartrate	138	19
Trazodone Hcl	Trazodone Hcl	124	21
Jardiance	Empagliflozin	116	suppressed
Metoprolol Succinate	Metoprolol Succinate	113	20
Simvastatin	Simvastatin	110	12
Tamsulosin Hcl	Tamsulosin Hcl	102	16
Losartan Potassium	Losartan Potassium	101	16
Donepezil Hcl	Donepezil Hcl	97	14
Baclofen	Baclofen	93	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	93	15
Tradjenta	Linagliptin	93	suppressed
Spironolactone	Spironolactone	91	13
Aripiprazole	Aripiprazole	86	suppressed
Meloxicam	Meloxicam	83	suppressed
Xarelto	Rivaroxaban	82	suppressed
Amlodipine Besylate	Amlodipine Besylate	81	13
Metformin Hcl	Metformin Hcl	81	suppressed
Carvedilol	Carvedilol	76	suppressed
Torsemide	Torsemide	75	suppressed
Mirtazapine	Mirtazapine	69	suppressed
Clopidogrel	Clopidogrel Bisulfate	68	suppressed
Duloxetine Hcl	Duloxetine Hcl	68	13
Escitalopram Oxalate	Escitalopram Oxalate	68	11
Rosuvastatin Calcium	Rosuvastatin Calcium	66	12
Levetiracetam	Levetiracetam	60	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	58	suppressed
Lisinopril	Lisinopril	58	13
Diclofenac Sodium	Diclofenac Sodium	55	16
Buspirone Hcl	Buspirone Hcl	54	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	51	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	49	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	49	suppressed
Lamotrigine	Lamotrigine	46	suppressed
Januvia	Sitagliptin Phosphate	45	suppressed
Midodrine Hcl	Midodrine Hcl	44	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	42	16
Combivent Respimat	Ipratropium/Albuterol Sulfate	41	suppressed
Cephalexin	Cephalexin	40	23
Warfarin Sodium	Warfarin Sodium	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Famotidine	Famotidine	37	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	35	suppressed
Prednisone	Prednisone	34	11
Divalproex Sodium	Divalproex Sodium	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Primidone	Primidone	33	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Lactulose	Lactulose	32	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Methocarbamol	Methocarbamol	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Xifaxan	Rifaximin	28	suppressed
Prazosin Hcl	Prazosin Hcl	27	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	14
Bumetanide	Bumetanide	23	suppressed
Finasteride	Finasteride	23	suppressed
Myrbetriq	Mirabegron	22	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Ozempic	Semaglutide	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	11
Bupropion Xl	Bupropion Hcl	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	12
Ranolazine Er	Ranolazine	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Methimazole	Methimazole	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error